Ridwan Islam, PhD

Director, Business Development

Ridwan Islam is a Business Development Director at Sygnature Discovery. He has more than 10 years of experience spanning academic research, pharmaceutical R&D, and business development, with previous roles at Crystal Pharmatech, Alkermes, Berkeley Lab, the FDA, and the University of Nebraska Medical Center. Drawing on extensive expertise in target discovery, molecular and cellular pharmacology, and preclinical drug development, Ridwan specializes in supporting strategic partnerships and advancing innovative therapeutic programs. His published and translational research experience has contributed to the discovery and development of novel drug candidates, helping bridge the gap between early-stage science and successful drug development across a range of disease areas.